Overview
Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
To collect post-marketing safety and effectiveness information on the use of Tiotropium Inhalation Capsules (18 μg) in patients with chronic obstructive pulmonary disease in daily clinical settingsAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Boehringer IngelheimTreatments:
BromidesTiotropium Bromide
Criteria
Inclusion Criteria:- Patients with COPD
Exclusion Criteria:
-There is no exclusion criterion, because this post marketing study (PMS) is observational
survey under condition of normal clinical practice